Scientists have reversed the aging process in mice: Are humans next?
Johns Hopkins' Dr. Marty Makary says it may sound like "pie in the sky," but the aging process may be reversible after new findings from Harvard scientists.
Florida's condo reserves law will 'end up bankrupting a lot of people': Joe Pinion
A 'Mornings with Maria' panel discusses how Florida's newest safety requirements for high-rise condos and apartments will impact homeowners.
J&J slashes production of its unpopular COVID-19 shot
A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration.
Moderna CEO says COVID moving into endemic stage
Moderna CEO Stephane Bancel discusses the future of the COVID pandemic, booster shots, and the company's outlook for 2023.
Rite Aid announces Heyward Donigan exit, appointment of interim CEO
Rite Aid experienced a leadership shakeup as the pharmacy change announce CEO Heyward Donigan's exit and the appointment of an interim chief executive.
Shares of GE's health care spinoff make trading debut on Nasdaq
Trading of GE HealthCare Technologies shares kicked off Wednesday morning, marking its debut as an independent company from conglomerate General Electric.
FDA approval of Alzheimer's drug Aduhelm 'rife with irregularities,' House report says
A report by two House committees found that the Food and Drug Administration's controversial approval of the Alzheimer's drug Aduhelm was "rife with irregularities."
House committee questions Biogen drug approval process
The FDA's approval process of Biogen's Alzheimer's drug was questioned in a Congressional report released Thursday.
Baby-formula imports to face tariffs again in 2023
Tariffs on baby formula are set to resume in the new year, despite supply chain issues and some still empty shelves.
Apple faces class-action lawsuit alleging 'racial bias' in watch's blood oximeter
Apple is facing a class-action lawsuit that alleges the Apple Watch's blood oximeter has a "racial bias" against individuals with darker skin tones.
Chili’s donates $100 million to St. Jude in major 20-year milestone
As of Dec. 15th this year, restaurant brand Chili's has raised $100 million for St. Jude Children's Research Hospital since launching the partnership in 2002.
Notable mergers and acquisitions moves in 2022
With another year of deal-making rapidly coming to a close, FOX Business takes a look at some of 2022's notable M&A activity in sectors including tech, health care and real estate.
Corporate health perks: How to take advantage of all your company’s offerings
Companies offer benefits to attract employees, increase retention and improve productivity. Many benefits packages include wellness programs few employees use.
California changing pay requirement for workers with COVID-19
California regulators voted Thursday to end a rule requiring companies to pay employees who can't work because they got infected with COVID-19 while on the job.
White House resumes program sending free COVID tests to households
The White House announced its COVID-19 Winter Preparedness Plan and made free COVID-19 tests available to all U.S. households again to deal with an increase in cases.
Doctor warns 'tridemic' could get worse if masks mandated again
A New York City doctor is warning that bringing back mask mandates — especially for kids — could make the "tridemic" worse.
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults
According to a study published in The New England Journal of Medicine, the Johnson & Johnson's and Merck's vaccines for Ebola created lasting antibodies.
Moderna looks to inspire ‘revolution’ in cancer treatments: CEO
Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers.
Amgen to buy Horizon Therapeutics for $26.4B
Amgen Inc. announced on Monday that it will acquire Horizon Therapeutics for $26 billion to further grow the company’s medical legacy. Horizon's best-selling drug is Tepezza.
Former Theranos exec Sunny Balwani sentenced to 13 years in prison
Former Theranos president Ramesh "Sunny" Balwani, Elizabeth Holmes' top deputy, was sentenced Wednesday to 13 years in prison for defrauding investors.



















